MS
Mark A Schlossberg
SVP - Legal & General Counsel

Mark A Schlossberg insider trades: Cytokinetics (CYTK) stock buys and sales

SVP - Legal & General Counsel, Cytokinetics Last trade Mar 15, 2022 39 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2013
3
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mark reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 15, 2022CYTK↓ Sell$856K
Oct 19, 2021CYTK↓ Sell$714K
Aug 21, 2020CYTK↓ Sell$250K
Jul 29, 2020CYTK↓ Sell$231K
Sep 11, 2015IPXL↓ Sell$323K
Aug 27, 2015IPXL↓ Sell$202K
Mar 12, 2013IPXL↑ Buy$17K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CYTK insiders

Open-market trades in the last 12 months

About Mark A Schlossberg's insider trades

Mark A Schlossberg is SVP - Legal & General Counsel at Cytokinetics (CYTK). Since Mar 12, 2013, Mark has reported 1 open-market purchase worth $17K and 6 sales worth $2.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (20 filings), grants and awards (14 filings), option exercises (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.